Home › Drug Codes › C Codes › C9313 · Decnupaz
Updated October 1st, 2026

Decnupaz C Code: C9313

Injection, pivekimab sunirine-pvzy, 0.01 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q4 2026
APC Payment Limit ?
$475.476
/ HCPCS billing unit · APC 0960
ASP ?
No current ASP
Not available for Q4 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, pivekimab sunirine-pvzy, 0.01 mg
HCPCS Added Date October 1, 2026
Manufacturer AbbVie
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Powder, Lyophilized, For Solution

About Decnupaz

Decnupaz is a medication aligned to the HCPCS C Code: C9313 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by AbbVie.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to C9313. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Decnupaz CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Decnupaz Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Decnupaz billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for Decnupaz.
Are there any available Decnupaz patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for Decnupaz.
Where can I find Decnupaz prescribing information?
Decnupaz prescribing information can be found at the link below. Please reach out to us if you believe this information to be inaccurate or out of date. Visit Here →
Where can I find Decnupaz side effect information?
Our team has not yet identified a source of side effects information for Decnupaz. Please check back in a few weeks.
Does billing Decnupaz require JZ/JW wastage modifiers?
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.